Corundum Systems Biology
Overview
Corundum Systems Biology is a venture capital investment firm based in Tokyo, Japan. The firm seeks to invest in healthcare start-ups related to the microbiome. They address the fundamental challenges of healthy longevity through a 'systems' approach to funding scientific research. By looking at the interaction of the body's ecosystems to understand the underlying causes of disease, it supports the development of targeted interventions to delay or prevent the onset of disease. CSB provides access to funding, resources, and mentorship to help researchers and entrepreneurs bring solutions to commercialization.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Concerto Biosciences | Nov 2022 | Series A | Co-investor |
| Vertero Therapeutics | Oct 2021 | Series C | Co-investor |
| Sequential | Mar 2026 | Seed | Lead |
| Holobiome | Oct 2024 | Seed | Co-investor |
| Nimble Science | Oct 2025 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Key People
Yasushi Yamamoto
Founder & Executive Director
Henry Haiser
Operating Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Corundum Systems Biology based?
Corundum Systems Biology is headquartered in Tokyo, Tokyo, Japan.
When was Corundum Systems Biology founded?
Corundum Systems Biology was founded in 2020.
How many portfolio companies does Corundum Systems Biology have?
Corundum Systems Biology has 8 portfolio companies in Caplight's dataset.
What are some companies in Corundum Systems Biology's portfolio?
Portfolio companies visible on Caplight include Concerto Biosciences, Vertero Therapeutics, Sequential, Holobiome, Nimble Science.
What was Corundum Systems Biology's most recent investment shown here?
Corundum Systems Biology's most recent investment in this portfolio sample was in Sequential in 2026.
What sectors does Corundum Systems Biology focus on?
Corundum Systems Biology focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Corundum Systems Biology focus on?
Corundum Systems Biology typically invests at the Early stage.
What is Corundum Systems Biology's AUM?
Corundum Systems Biology's assets under management are estimated between $50.0M and $100.0M.